| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/12/1993 | US5178863 Microorganisms detoxifying fusaric acid and method for detoxifying fusaric acid by the use of the same |
| 01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
| 01/12/1993 | CA1312569C Csf and method for obtaining the same |
| 01/12/1993 | CA1312567C Yeast strains with reduced intracellular atp levels |
| 01/11/1993 | CA2113083A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 01/10/1993 | CA2073373A1 Bacillus strain and insect pest controlling agent |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000435A1 Adn sequences of the human papillomavirus type 42, and diagnostic application thereof |
| 01/07/1993 | WO1993000434A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | WO1993000433A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | WO1993000432A1 Bmp-9 compositions |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000426A1 Mammalian pancreatic lipase and variant thereof |
| 01/07/1993 | WO1993000425A1 A novel receptor-type tyrosine kinase and use thereof |
| 01/07/1993 | WO1993000422A1 Gram-positive alkaliphilic microorganisms |
| 01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
| 01/07/1993 | WO1993000111A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000049A1 Osteogenic factor |
| 01/07/1993 | EP0521842A2 Tumor antigen specific antibody |
| 01/07/1993 | EP0521767A1 Production process of recombinant proteins and used host cells |
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 01/07/1993 | EP0521464A1 Antibiotic, phencomycin, a process for its production and its use |
| 01/07/1993 | EP0521427A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | EP0521348A1 Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same |
| 01/07/1993 | EP0521318A2 Hepatitis C diagnostics and vaccines |
| 01/07/1993 | EP0521240A2 Novel bacteriocin from lactococcus lactis subspecies lactis |
| 01/07/1993 | EP0521104A1 Method for the production of eicosapentaenoic acids |
| 01/07/1993 | EP0484440A4 Efficient directional genetic cloning system |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | CA2093790A1 Osteogenic factor |
| 01/06/1993 | CN1067681A 发酵 Ferment |
| 01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
| 01/06/1993 | CA2073085A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening inhibitors of human cytomegalovirus |
| 01/05/1993 | US5177197 Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein |
| 01/05/1993 | US5177193 In vivo half-life, genetic engineering |
| 01/05/1993 | US5177017 Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum |
| 01/05/1993 | US5177016 Monoclonal antibody recognizing anthracycline glycoside specific epitope and hybridoma secerning the antibody |
| 01/05/1993 | US5177001 In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor |
| 01/05/1993 | US5176911 Topical compositions for use in gynecology and urology |
| 01/05/1993 | CA1312299C Process for producing glucose isomerase |
| 01/02/1993 | WO1993000925A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2090463A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 12/30/1992 | EP0520757A2 Material for promoting growth of bacteria |
| 12/30/1992 | EP0520756A2 Method for lysing mycobacteria |
| 12/30/1992 | EP0520557A1 A process for the glycosylation of avermectin compounds |
| 12/30/1992 | EP0520554A2 C-21 hydroxylated FK-506 antagonist |
| 12/30/1992 | EP0520436A2 Monoclonal antibody, method of production thereof and use thereof |
| 12/30/1992 | EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor |
| 12/30/1992 | EP0520027A1 Process for the production of natural long-chain alcohols |
| 12/30/1992 | EP0465494B1 Process for fermentative production of 2-(4-hydroxyphenoxy-)propionic acid |
| 12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
| 12/29/1992 | WO1993000439A1 In vivo delivery of active factors by co-cultured cell implants |
| 12/29/1992 | WO1993000012A1 Manipulation of intestinal structure and enzymes in animals |
| 12/29/1992 | US5175277 Rapidly hydrating welan gum |
| 12/29/1992 | US5175147 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 12/29/1992 | US5175108 Compatible, stable; genetic engineering |
| 12/29/1992 | US5175107 Used as medical-use nutritive mixtures, as fodder additie of animals, chemical and pharmaceutical reagent, and growth factor for microorganisms production other amino acids such as L-lysin, L-homoerin |
| 12/29/1992 | US5175105 Process for the production of urokinase using saccharomyes cerevisiae |
| 12/29/1992 | US5175104 Gene coding for phosphotransacetylase inserted into vector dna |
| 12/29/1992 | US5175101 Recombinant restriction enzyme sau3ai |
| 12/29/1992 | US5175096 Dna encoding a fibronectin binding protein as well as its preparation |
| 12/29/1992 | CA2093131A1 Manipulation of intestinal structure and enzymes in animals |
| 12/29/1992 | CA2072412A1 Monoclonal antibody, method of production thereof and use thereof |
| 12/29/1992 | CA2071655A1 Sporormiella intermedia and processes therefrom |
| 12/29/1992 | CA1312031C Process for the purification of serum albumin |
| 12/29/1992 | CA1312028C Expression vectors containing the heat shock regulatory dna sequences from a heat shock protein 83 (hsp83) gene and inducible expression by use of the vectors |
| 12/29/1992 | CA1312026C Plasmid vectors for efficient expression of genes in e. coli |
| 12/29/1992 | CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas |
| 12/28/1992 | CA2072246A1 Ccv vaccine |
| 12/28/1992 | CA2071723A1 Culture of exserohilum rostratum and processes therefrom |
| 12/27/1992 | CA2071574A1 Process for the glycosylation of avermectin compounds |
| 12/26/1992 | CA2071332A1 C-21 hydroxylated fk-506 antagonist |
| 12/24/1992 | DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria |
| 12/23/1992 | WO1992022665A1 Production and recovery of recombinant neurotrophins |
| 12/23/1992 | WO1992022664A1 Chemotactic factor |
| 12/23/1992 | WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 12/23/1992 | WO1992022655A1 Hepatitis c diagnostics and vaccines |
| 12/23/1992 | WO1992022653A1 Method for making humanized antibodies |
| 12/23/1992 | WO1992022652A1 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM |
| 12/23/1992 | WO1992022584A1 Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 12/23/1992 | WO1992022326A1 Insertional mutations in mycobacteria |
| 12/23/1992 | WO1992022324A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | WO1992022314A1 Purified chitinases and use thereof |
| 12/23/1992 | WO1992017588A3 Method for production of an iga binding protein derived from group b streptococci |
| 12/23/1992 | WO1992016602A3 Multistage system for deep desulfurization of fossil fuels |
| 12/23/1992 | EP0519889A2 Leydig cell stimulator |
| 12/23/1992 | EP0519866A1 Novel anti-HIV antibodies |
| 12/23/1992 | EP0519728A2 Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies |
| 12/23/1992 | EP0519547A2 Coccidiosis poultry vaccine |
| 12/23/1992 | EP0519512A2 Microbiological process for the preparation of 5-hydroxy pyrazinc carboxylic acid |
| 12/23/1992 | EP0519469A1 Cloned glutamic acid decarboxylase |
| 12/23/1992 | EP0519336A2 Chimeric gene comprising a promoter-regulater and a gene coding for an indicator protein |
| 12/23/1992 | EP0519229A2 Alkaline protease gene from fusarium sp |
| 12/23/1992 | EP0519218A2 Hybrid-plasmid for the 38 kDa antigen from M. tuberculosis, E. coli as host, the 38 kDa antigen and a 33 kDa protein |
| 12/23/1992 | EP0519070A1 Method of judging type of human leukocyte antigen |